Skip to Main Content

Paper Details

Acute pharmacodynamic responses to exenatide: Drug-induced increases in insulin secretion and glucose effectiveness.
Diabetes Obes Metab
2
2023
Exenatide, Glucagon-like peptide-1 receptor, exenatide, genetic variants, glucagon-like peptide-1 receptor, glucose, insulin, participants, patients, semaglutide, type 2 diabetes
Author NameAffiliation
May E MontasserUniversity of Maryland School of Medicine
Braxton D MitchellUniversity of Maryland School of Medicine
Alan R ShuldinerUniversity of Maryland School of Medicine
Alan R ShuldinerUniversity of Maryland School of Medicine
Amber L BeitelsheesUniversity of Maryland School of Medicine
  • 1 - 5

Datasets

Release 1.2